Miami Clinical Research Expands in 2022-23: New Diagnostic and Imaging Center and PB&C Lab

At Miami Clinical Research, we are excited to announce the launch of our 2022-23 Expansion Project. This project includes the addition of a complete diagnostic and imaging center and a PB&C (pharmaceuticals, biologics, and chemicals) lab to our existing clinical trials and medical research facilities. 


The new diagnostic and imaging center will provide a comprehensive suite of imaging and diagnostic services to our clinical research partners. This includes access to world-class imaging technology, such as MRI, CT, PET and X-ray scans. The PB&C lab will perform advanced testing of pharmaceutical and biologic products, as well as provide quality control and safety testing of products in development. 


These new facilities will enable Miami Clinical Research to provide a wide range of services and support to our clinical research partners. Our team of experienced professionals is well-equipped to provide the highest level of care to our partners and their patients. We are committed to providing our partners with the highest quality of service, and these new additions to our facilities will give us the necessary resources to do so. 


At Miami Clinical Research, we are passionate about advancing medical research and helping to improve patient outcomes. Our Expansion Project is part of our commitment to providing our clinical research partners with the highest levels of quality and service. We look forward to continuing to work with our partners and providing them with the resources they need to succeed. 


If you are interested in learning more about our Expansion Project, please contact us today. We look forward to hearing from you and helping you achieve your research goals.